{"organizations": [], "uuid": "ebaeb9a8d714d4c6760e2b35be0e5007c773f997", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/3", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/30/business-wire-experienced-life-science-ip-and-fda-attorneys-join-halloran-farkas-kittila-llp.html", "country": "US", "domain_rank": 767, "title": "Experienced Life Science IP and FDA Attorneys Join Halloran Farkas + Kittila LLP", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-30T18:00:00.000+03:00", "replies_count": 0, "uuid": "ebaeb9a8d714d4c6760e2b35be0e5007c773f997"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/30/business-wire-experienced-life-science-ip-and-fda-attorneys-join-halloran-farkas-kittila-llp.html", "ord_in_thread": 0, "title": "Experienced Life Science IP and FDA Attorneys Join Halloran Farkas + Kittila LLP", "locations": [], "entities": {"persons": [{"name": "halloran farkas", "sentiment": "negative"}, {"name": "michael j. keller", "sentiment": "none"}, {"name": "edgar asebey", "sentiment": "none"}, {"name": "michael keller", "sentiment": "none"}, {"name": "keller", "sentiment": "none"}, {"name": "j.d.", "sentiment": "none"}, {"name": "edgar j. asebey", "sentiment": "none"}], "locations": [{"name": "florida office pompano beach", "sentiment": "none"}, {"name": "fla.", "sentiment": "none"}, {"name": "palo alto", "sentiment": "none"}, {"name": "wyoming", "sentiment": "none"}, {"name": "california", "sentiment": "none"}, {"name": "georgia", "sentiment": "none"}, {"name": "washington d.c.", "sentiment": "none"}, {"name": "wilmington", "sentiment": "none"}, {"name": "delaware", "sentiment": "none"}, {"name": "florida", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "george washington university", "sentiment": "none"}, {"name": "department of energy", "sentiment": "none"}, {"name": "vycellix, inc.", "sentiment": "none"}, {"name": "national cancer institute", "sentiment": "none"}, {"name": "uspto", "sentiment": "none"}, {"name": "jackson hole", "sentiment": "none"}, {"name": "ivax corporation", "sentiment": "none"}, {"name": "nih", "sentiment": "none"}, {"name": "university of georgia", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Firm Opens South Florida Office\nPOMPANO BEACH, Fla.--(BUSINESS WIRE)-- Halloran Farkas + Kittila LLP announced today Michael Keller and Edgar Asebey joined the firm April 2, 2018. HFK currently has offices in Palo Alto, California; Washington D.C.; Wilmington, Delaware; and Jackson Hole, Wyoming.\nMichael J. Keller practices intellectual property law, primarily in the life sciences with 26 years of patent prosecution and transactional experience.\nMr. Keller founded and is currently an EVP for Vycellix, Inc., a cellular cancer therapeutics company. Previously he served as Chief Patent Counsel of IVAX Corporation and GMP Companies. He started his legal career in technology transfer for the Department of Energy and the National Cancer Institute at NIH. He holds a J.D. and B.S. from the University of Georgia and was a Ph.D. candidate at the George Washington University. He is admitted to practice in Georgia, Florida, and before the USPTO.\nEdgar J. Asebey is a life sciences regulatory and transactional attorney with over 20 years of experience advising clients in the medical device, pharmaceutical, biotechnology, food, dietary supplement, and cosmetics industries on FDA regulatory, transactional and venture finance matters.\nPreviously Mr. Asebey was a Life Sciences partner at Jones Day. Early in his career, Mr. Asebey worked as a patent and licensing advisor at the National Cancer Institute at NIH. After leaving the NCI, Mr. Asebey founded and was CEO of a drug discovery company. He holds a B.A. from The University of Chicago and a J.D. from The Catholic University of America in Washington, D.C. and is admitted to practice in Florida and D.C.\nManaging Partner Theodore A. Kittila commented, “We are thrilled to have Mike and Edgar join the firm as they add significant depth to our expanding life science practice.” Mr. Keller stated, “HFK is highly regarded for its corporate and intellectual property work and we are thrilled to join forces with such talented attorneys.”\nHFK is a law firm focusing on corporate and complex commercial matters, litigation, intellectual property, and FDA regulatory matters. The firm’s new offices will be located at 351 S. Cypress Road, Suite 307, Pompano Beach, FL 33060.\nView source version on businesswire.com : https://www.businesswire.com/news/home/20180430005094/en/\nHalloran Farkas + Kittila LLP\nTheodore A. Kittila, Attorney at Law\nManaging Partner\n302-257-2025\nSource: Halloran Farkas + Kittila LLP", "external_links": ["http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.hfk.law&esheet=51797120&newsitemid=20180430005094&lan=en-US&anchor=Halloran+Farkas+%2B+Kittila+LLP&index=1&md5=2ab69b8173bf46cc83665107132d1ad1", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.hfk.law&esheet=51797120&newsitemid=20180430005094&lan=en-US&anchor=HFK&index=2&md5=b99df3c96ca59e93e21cd76347b31b63", "https://www.businesswire.com/news/home/20180430005094/en/"], "published": "2018-04-30T18:00:00.000+03:00", "crawled": "2018-04-30T20:29:49.020+03:00", "highlightTitle": ""}